BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12694522)

  • 1. A new ELISA assay for diagnosis of acquired von Willebrand syndrome.
    Siaka C; Rugeri L; Caron C; Goudemand J
    Haemophilia; 2003 May; 9(3):303-8. PubMed ID: 12694522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A two-step approach (Enzyme-linked immunosorbent assay and confirmation assay) to detect antibodies against von Willebrand factor in patients with Acquired von Willebrand Syndrome.
    Franchi F; Biguzzi E; Stufano F; Siboni SM; Baronciani L; Peyvandi F
    Thromb Res; 2014 Dec; 134(6):1316-22. PubMed ID: 25300810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired von Willebrand syndrome associated with Hashimoto's thyroiditis and subcutaneous mucosa-associated lymphoid tissue lymphoma.
    Koyama T; Fujimoto K; Shima M
    Intern Med; 2013; 52(23):2661-3. PubMed ID: 24292759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory Testing for von Willebrand Factor Antigen (VWF:Ag).
    Favaloro EJ; Mohammed S; Patzke J
    Methods Mol Biol; 2017; 1646():403-416. PubMed ID: 28804844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of intravenous immunoglobulin in patients with acquired von Willebrand syndrome.
    Federici AB
    Hum Immunol; 2005 Apr; 66(4):422-30. PubMed ID: 15866707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct mechanisms account for acquired von Willebrand syndrome in plasma cell dyscrasias.
    Dicke C; Schneppenheim S; Holstein K; Spath B; Bokemeyer C; Dittmer R; Budde U; Langer F
    Ann Hematol; 2016 May; 95(6):945-57. PubMed ID: 27040683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory Testing for von Willebrand Factor Collagen Binding (VWF:CB).
    Favaloro EJ; Mohammed S
    Methods Mol Biol; 2017; 1646():417-433. PubMed ID: 28804845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel ELISA-based diagnosis of acquired von Willebrand disease with increased VWF proteolysis.
    Rauch A; Caron C; Vincent F; Jeanpierre E; Ternisien C; Boisseau P; Zawadzki C; Fressinaud E; Borel-Derlon A; Hermoire S; Paris C; Lavenu-Bombled C; Veyradier A; Ung A; Vincentelli A; van Belle E; Lenting PJ; Goudemand J; Susen S
    Thromb Haemost; 2016 May; 115(5):950-9. PubMed ID: 26791163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acquired von Willebrand syndrome in a patient with immune thrombocytopenic purpura].
    Ihara A; Suzuki N; Matsushita T; Ichinose A
    Rinsho Ketsueki; 2015 Jul; 56(7):901-4. PubMed ID: 26256928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic lupus erythematosus complicated by acquired von Willebrand's syndrome.
    Hong S; Lee J; Chi H; Lee C; Nah S; Kim Y; Oh J; Moon H; Yoo B
    Lupus; 2008 Sep; 17(9):846-8. PubMed ID: 18755868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired von Willebrand syndrome--report of 10 cases and review of the literature.
    Nitu-Whalley IC; Lee CA
    Haemophilia; 1999 Sep; 5(5):318-26. PubMed ID: 10583513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Causes, etiology and diagnosis of acquired von Willebrand disease: a prospective diagnostic workup to establish the most effective therapeutic strategies.
    Sucker C; Michiels JJ; Zotz RB
    Acta Haematol; 2009; 121(2-3):177-82. PubMed ID: 19506364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and immediate treatment of acquired von Willebrand syndrome revealed by recurrent cerebral hemorrhage.
    Pineau-Vincent F; Legout A; Besancon-Bergelin A; Alani M; Laribi K; Lemaire P
    Transfus Clin Biol; 2019 Nov; 26(4):356-358. PubMed ID: 31262628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management.
    Michiels JJ; Budde U; van der Planken M; van Vliet HH; Schroyens W; Berneman Z
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):401-36. PubMed ID: 11686107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and treatment of acquired von Willebrand syndrome.
    Tiede A
    Thromb Res; 2012 Dec; 130 Suppl 2():S2-6. PubMed ID: 23439003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune-mediated etiology of acquired von Willebrand syndrome in systemic lupus erythematosus and in benign monoclonal gammopathy: therapeutic implications.
    Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; Budde U; van Vliet HH
    Semin Thromb Hemost; 2006 Sep; 32(6):577-88. PubMed ID: 16977568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory Testing for von Willebrand Factor: Factor VIII Binding (for 2N VWD).
    Mohammed S; Favaloro EJ
    Methods Mol Biol; 2017; 1646():461-472. PubMed ID: 28804848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired von Willebrand syndrome: an update.
    Franchini M; Lippi G
    Am J Hematol; 2007 May; 82(5):368-75. PubMed ID: 17133419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct Mechanisms of IgM Antibody-Mediated Acquired von Willebrand Syndrome and Successful Treatment with Recombinant von Willebrand Factor in One Patient.
    Höpting M; Budde U; Tiede A; Grube M; Hahn J; Herr W; Heimerl S; Hart C
    Acta Haematol; 2022; 145(4):454-457. PubMed ID: 35086107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibody to von Willebrand factor in systemic lupus erythematosus.
    Soff GA; Green D
    J Lab Clin Med; 1993 Mar; 121(3):424-30. PubMed ID: 8445290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.